High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease

High body mass index is not associated with increased treatment failure in infliximab treated pediatric patients with inflammatory bowel disease

Background and Aim While weight gain during infliximab therapy in inflammatory bowel disease (IBD) is common, there has been limited research evaluating its impact on infliximab efficacy. Methods Primary aims of this study were to determine the frequency of excess weight gain (body mass index [BMI] ...

Full description

Bibliographic Details
Main Authors: Isaac Rodin, Justin Chan, Laura Meleady, Clare Hii, Sally Lawrence, Kevan Jacobson
Format: Article
Language:English
Published: Wiley 2020-06-01
Series:JGH Open
Subjects:
body mass index
infliximab
obesity
pediatric inflammatory bowel disease
Online Access:https://doi.org/10.1002/jgh3.12277

Similar Items

Similar Items